C the Signs (Series A)
Funding Details
Awarder
Inbox
Date Award
January 31, 2025
Vertical
Health Tech and Medtech
Funding Amount
$8,000,000
Company Info
Traction
C the Signs has already helped detect tens of thousands of cancers across the National Health Service (NHS) in the UK, achieving a sensitivity of 93.8% in identifying patients at risk of colorectal cancer.
Market
Cancer Detection
Location
London, United Kingdom
Company Description

C the Signs gives GPs the ability to simultaneously check combinations of signs, symptoms and risk factors, in an easy to use format.